Hemant Kumar Misra is a notable inventor based in Shrewsbury, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of antibody formulations for the treatment of hepatitis B virus (HBV) infections. With a total of 2 patents, his work has the potential to impact the lives of many affected by this virus.

Latest Patents

Misra's latest patents focus on stabilized anti-hepatitis B (HBV) antibody formulations. These inventions provide liquid formulations of antibodies or fragments that specifically bind to HBV antigens. The formulations exhibit remarkable stability, with low to undetectable levels of aggregation, ensuring minimal loss of biological activity even during extended storage periods. Furthermore, these inventions offer methods for preventing, treating, or ameliorating symptoms associated with HBV infection, showcasing their therapeutic potential.

Career Highlights

Hemant Kumar Misra has established himself as a key figure in the biotechnology sector. His innovative work at Yeda Research and Development Co. Ltd. has positioned him at the forefront of research aimed at combating viral infections. His dedication to advancing medical science is evident in his patent contributions.

Collaborations

Misra has collaborated with esteemed colleagues, including Rachel Eren and Walter G Gowan, Jr. These partnerships have fostered a collaborative environment that enhances the research and development of effective treatments for HBV.

Conclusion

In summary, Hemant Kumar Misra is a distinguished inventor whose work in developing stabilized anti-hepatitis B antibody formulations holds promise for improving treatment options for those affected by HBV. His contributions to biotechnology reflect a commitment to innovation and public health.